Torben Sigsgaard

Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Time domain and flow indices of bronchial hyperresponsiveness : association with asthma symptoms, atopy and smoking. / Miller, Martin; Sigsgaard, Torben; Omland, O; Pedersen, Ole Finn.

I: European Respiratory Journal, Bind 20, Nr. 1, 07.2002, s. 86-91.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Miller, M, Sigsgaard, T, Omland, O & Pedersen, OF 2002, 'Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking', European Respiratory Journal, bind 20, nr. 1, s. 86-91.

APA

Miller, M., Sigsgaard, T., Omland, O., & Pedersen, O. F. (2002). Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking. European Respiratory Journal, 20(1), 86-91.

CBE

MLA

Vancouver

Miller M, Sigsgaard T, Omland O, Pedersen OF. Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking. European Respiratory Journal. 2002 jul;20(1):86-91.

Author

Miller, Martin ; Sigsgaard, Torben ; Omland, O ; Pedersen, Ole Finn. / Time domain and flow indices of bronchial hyperresponsiveness : association with asthma symptoms, atopy and smoking. I: European Respiratory Journal. 2002 ; Bind 20, Nr. 1. s. 86-91.

Bibtex

@article{145a1d8063c44ee08f222191185f042f,
title = "Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking",
abstract = "Conventional measures of bronchial hyperresponsiveness (BHR) are only weakly associated with respiratory symptoms in epidemiological studies. Partial and maximal forced expiratory manoeuvres were recorded during histamine challenge testing in 1,959 young male farmers. Analysis was performed to test whether novel measures of BHR, using alternative flow and time domain indices, are more closely associated with asthma symptoms, smoking status and atopy than forced expiratory volume in one second (FEV1) and conventional measures of BHR. The first moments to 75{\%} and 90{\%} of the forced vital capacity (FVC) were calculated from full (F) and partial (P) forced expiratory manoeuvres (i.e. alpha1 75{\%}F, alpha1 75{\%}P), together with the instantaneous flows when 40{\%} and 30{\%} of the FVC remained to be expired (MEF40 and MEF30). BHR was measured by the provocative dose causing a 20{\%} change (PD20) in the FEV1 and alpha1 75{\%}, and also by the method of log dose slopes (LDS). Asthma was diagnosed from symptoms associated with asthma in 158 (8.1{\%}) of the subjects. PD20 FEV1 could only be recorded in 190 subjects (9.7{\%}), of whom only 48 had asthma, whereas LDSFEV1 was recorded in 1,725 (88{\%}) subjects. From the prechallenge data, alpha1 75{\%}, expressed as standardised residuals, showed the largest difference between smokers with and without asthma symptoms, and no indices showed significant differences between nonsmokers with and without asthma symptoms. From BHR data in both smokers and nonsmokers, LDSFEV1 showed one of the largest differences between those with and without asthma symptoms. With smoking status and atopy accounted for, the greatest partial correlation with asthma diagnosis was found for LDSMEF40P, and then for LDSFEV1, but LDSMEF40P was measurable in only just over one-half of the subjects. The authors conclude that time-domain indices are promising measures for longitudinal epidemiological studies concerning the relationship between bronchial hyperresonsiveness and environmental exposures. However, indices from the partial flow-volume loop suffer from censored data.",
keywords = "Adult, Asthma, Bronchial Hyperreactivity, Bronchial Provocation Tests, Forced Expiratory Flow Rates, Forced Expiratory Volume, Humans, Male, Reproducibility of Results, Respiratory Hypersensitivity, Sensitivity and Specificity, Smoking, Time Factors, Vital Capacity",
author = "Martin Miller and Torben Sigsgaard and O Omland and Pedersen, {Ole Finn}",
year = "2002",
month = "7",
language = "English",
volume = "20",
pages = "86--91",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",

}

RIS

TY - JOUR

T1 - Time domain and flow indices of bronchial hyperresponsiveness

T2 - association with asthma symptoms, atopy and smoking

AU - Miller, Martin

AU - Sigsgaard, Torben

AU - Omland, O

AU - Pedersen, Ole Finn

PY - 2002/7

Y1 - 2002/7

N2 - Conventional measures of bronchial hyperresponsiveness (BHR) are only weakly associated with respiratory symptoms in epidemiological studies. Partial and maximal forced expiratory manoeuvres were recorded during histamine challenge testing in 1,959 young male farmers. Analysis was performed to test whether novel measures of BHR, using alternative flow and time domain indices, are more closely associated with asthma symptoms, smoking status and atopy than forced expiratory volume in one second (FEV1) and conventional measures of BHR. The first moments to 75% and 90% of the forced vital capacity (FVC) were calculated from full (F) and partial (P) forced expiratory manoeuvres (i.e. alpha1 75%F, alpha1 75%P), together with the instantaneous flows when 40% and 30% of the FVC remained to be expired (MEF40 and MEF30). BHR was measured by the provocative dose causing a 20% change (PD20) in the FEV1 and alpha1 75%, and also by the method of log dose slopes (LDS). Asthma was diagnosed from symptoms associated with asthma in 158 (8.1%) of the subjects. PD20 FEV1 could only be recorded in 190 subjects (9.7%), of whom only 48 had asthma, whereas LDSFEV1 was recorded in 1,725 (88%) subjects. From the prechallenge data, alpha1 75%, expressed as standardised residuals, showed the largest difference between smokers with and without asthma symptoms, and no indices showed significant differences between nonsmokers with and without asthma symptoms. From BHR data in both smokers and nonsmokers, LDSFEV1 showed one of the largest differences between those with and without asthma symptoms. With smoking status and atopy accounted for, the greatest partial correlation with asthma diagnosis was found for LDSMEF40P, and then for LDSFEV1, but LDSMEF40P was measurable in only just over one-half of the subjects. The authors conclude that time-domain indices are promising measures for longitudinal epidemiological studies concerning the relationship between bronchial hyperresonsiveness and environmental exposures. However, indices from the partial flow-volume loop suffer from censored data.

AB - Conventional measures of bronchial hyperresponsiveness (BHR) are only weakly associated with respiratory symptoms in epidemiological studies. Partial and maximal forced expiratory manoeuvres were recorded during histamine challenge testing in 1,959 young male farmers. Analysis was performed to test whether novel measures of BHR, using alternative flow and time domain indices, are more closely associated with asthma symptoms, smoking status and atopy than forced expiratory volume in one second (FEV1) and conventional measures of BHR. The first moments to 75% and 90% of the forced vital capacity (FVC) were calculated from full (F) and partial (P) forced expiratory manoeuvres (i.e. alpha1 75%F, alpha1 75%P), together with the instantaneous flows when 40% and 30% of the FVC remained to be expired (MEF40 and MEF30). BHR was measured by the provocative dose causing a 20% change (PD20) in the FEV1 and alpha1 75%, and also by the method of log dose slopes (LDS). Asthma was diagnosed from symptoms associated with asthma in 158 (8.1%) of the subjects. PD20 FEV1 could only be recorded in 190 subjects (9.7%), of whom only 48 had asthma, whereas LDSFEV1 was recorded in 1,725 (88%) subjects. From the prechallenge data, alpha1 75%, expressed as standardised residuals, showed the largest difference between smokers with and without asthma symptoms, and no indices showed significant differences between nonsmokers with and without asthma symptoms. From BHR data in both smokers and nonsmokers, LDSFEV1 showed one of the largest differences between those with and without asthma symptoms. With smoking status and atopy accounted for, the greatest partial correlation with asthma diagnosis was found for LDSMEF40P, and then for LDSFEV1, but LDSMEF40P was measurable in only just over one-half of the subjects. The authors conclude that time-domain indices are promising measures for longitudinal epidemiological studies concerning the relationship between bronchial hyperresonsiveness and environmental exposures. However, indices from the partial flow-volume loop suffer from censored data.

KW - Adult

KW - Asthma

KW - Bronchial Hyperreactivity

KW - Bronchial Provocation Tests

KW - Forced Expiratory Flow Rates

KW - Forced Expiratory Volume

KW - Humans

KW - Male

KW - Reproducibility of Results

KW - Respiratory Hypersensitivity

KW - Sensitivity and Specificity

KW - Smoking

KW - Time Factors

KW - Vital Capacity

M3 - Journal article

C2 - 12166587

VL - 20

SP - 86

EP - 91

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 1

ER -